Logo image
Upadacitinib in active ankylosing spondylitis: results of the 2-year, double-blind, placebo-controlled SELECT-AXIS 1 study and open-label extension
Article de revue scientifique   Avec comité de lecture

Upadacitinib in active ankylosing spondylitis: results of the 2-year, double-blind, placebo-controlled SELECT-AXIS 1 study and open-label extension

Désirée van der Heijde, Atul Deodhar, Walter P Maksymowych, Joachim Sieper, Filip Van den Bosch, Tae-Hwan Kim, Mitsumasa Kishimoto, Andrew J Östör, Bernard Combe, Yunxia Sui, …
Rheumatic & musculoskeletal diseases open, Vol.8(2), p.e002280
Original research
01/07/2022
PMID: 35896281

Résumé

Spondyloarthritis

Indicateurs

1 Consultations de la notice

Détails

Logo image